arrow
R

Richard Pazdur

us food & drug administration (fda)
H指数:134
被引数:6.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials

美国食品药品监督管理局对一线晚期免疫肿瘤学肾细胞癌试验中根据缓解深度进行的总生存期合并分析

2025-08-010
OAAI
Advancing Global Health Equity in Oncology Clinical Trial Access
2024-09-240
PRE
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development
2023-12-121
PRE
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

抗生素与接受靶向或免疫治疗的肝细胞癌患者的不良肿瘤结局之间的关联

2023-06-0119
OAAI